Federal Register #DEA-1760

DEA Notice: Curia New York Inc. Application to Import Controlled Substances

This notice concerns Curia New York Inc.'s application to the Drug Enforcement Administration (DEA) for registration as an importer of controlled substances. - Government Buyer: - U.S. Department of Justice, Drug Enforcement Administration (DEA) - OEM/Vendor: - Curia New York Inc. - Products/Services Requested: - Importation of basic classes of controlled substances for bulk manufacturing: - Gamma Hydroxybutyric Acid (drug code 2010, Schedule I) - 4-Anilino-N-phenethyl-4-piperidine (ANPP) (drug code 8333, Schedule II) - Poppy Straw Concentrate (drug code 9670, Schedule II) - Unique/Notable Requirements: - Import is strictly for bulk manufacturing into other controlled substances for distribution to customers - No import of finished dosage forms is authorized - The DEA is soliciting public comments or requests for a hearing regarding this registration - No specific quantities or part numbers are provided, as this is a registration application, not a procurement of physical goods

Description

Curia New York Inc. has applied to be registered as an importer of basic classes of controlled substances including Gamma Hydroxybutyric Acid, 4-Anilino-N-phenethyl-4-piperidine (ANPP), and Poppy Straw Concentrate. The company plans to import these substances for bulk manufacturing into other controlled substances to be distributed to their customers. Comments on the application must be submitted electronically by September 25, 2026. Interested parties may request a hearing or submit objections by the same deadline.

View original listing